title: [Effects of Feitai Capsule on quality of life in patients with advanced non-small-cell lung cancer: a randomized controlled trial].
abstract: BACKGROUND
  Recently the maintenance therapy of non-small-cell lung cancer (NSCLC) patients who completed required treatment cycles has caused widespread interests in the medical field. Traditional Chinese medicine may be a useful complement in maintenance treatment of mid-to-late stage NSCLC.
  
  
  OBJECTIVE
  To observe the effects of Feitai Capsule, a compound traditional Chinese herbal medicine for expelling blood stasis and phlegm, on the quality of life of the NSCLC patients as a maintenance treatment.
  
  
  METHODS
  A total of 62 mid-to-late stage NSCLC patients from Fuzhou General Hospital of Nanjing Military Region were included and randomly divided into treatment group (31 cases) and control group (31 cases). Patients in the treatment group were treated with Feitai Capsule, and patients in the control group did not accept any intervention. Regular observations and follow-up were performed for patients in the two groups.
  
  
  METHODS
  Analysis of variance, nonparametric test, and analysis of covariance were used to compare clinical features, amelioration of clinical symptoms, physical constitution and energy, and quality of life.
  
  
  RESULTS
  There were two dropouts and 60 valid cases. The baseline characteristics of the two groups were similar. In the treatment group, symptom response and physical energy level were improved by 36.6% (Z=-2.632, P=0.008) and 26.7%(Z=-2.182, P=0.029), respectively. There was a positive correlation between these two factors (r=0.917, P<0.001). The patients in treatment group had a significantly improved quality of life after treatment. No serious adverse events were observed.
  
  
  CONCLUSIONS
  Feitai Capsule as maintenance treatment can improve the quality of life of the patients with mild-to-late stage NSCLC.
authors.affiliation: Department of Oncology, Fuzhou General Hospital of Nanjing Military Region, Fuzhou 350025, Fujian Province, China.
authors.forename: Zhi-zhen
authors.initials: ZZ
authors.lastname: Liu
authors.forename: Zong-yang
authors.initials: ZY
authors.lastname: Yu
authors.forename: Xue-nong
authors.initials: XN
authors.lastname: Ouyang
authors.forename: Xi-hu
authors.initials: XH
authors.lastname: Dai
authors.forename: Xi
authors.initials: X
authors.lastname: Chen
authors.forename: Zhong-quan
authors.initials: ZQ
authors.lastname: Zhao
authors.forename: Wen-wu
authors.initials: WW
authors.lastname: Wang
authors.forename: Jie
authors.initials: J
authors.lastname: Li
authors.forename: Hua
authors.initials: H
authors.lastname: Tu
authors.forename: Lei
authors.initials: L
authors.lastname: Ye
authors.forename: Yan
authors.initials: Y
authors.lastname: Yan
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002214:Capsules; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D008517:Phytotherapy; D011788:Quality of Life
chemical_list: D002214:Capsules; D004365:Drugs, Chinese Herbal; C500582:Feitai